Discover

MDT
Medtronic plc
82.39
1 x 82.40
1 x 85.50
bid
ask
+
0.38
0.46%
1 @ 07:50 AM
82.39 +0.00 (0.00%)
Ytd-14.23%
1y-7.43%
81.10
day range
83.00
72.97
52 week range
106.33
Open81.69Prev Close82.01Low81.10High83.00Mkt Cap105.46B
Vol5.50MAvg Vol10.32MEPS3.73P/E14.11Forward P/E12.80
Beta0.56Short Ratio1.59Inst. Own89.63%Dividend2.88Div Yield3.44
Ex Div Date06-26Earning08-1850-d Avg79.02200-d Avg91.091yr Est97.73
Earning
DateForEstimateReportedSurprisesurprise %
2026-06-032026-041.58N/AN/AN/A
2026-02-172026-011.331.360.032.26%
2025-11-182025-101.311.360.053.82%
2025-08-192025-071.231.260.032.44%
2025-05-212025-041.581.620.042.53%
2025-02-182025-011.361.390.032.21%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-06Evercore ISI GroupUpgradeOutperformOutperform
2026-06-17NeedhamUpgradeBuyBuy
2026-06-05Goldman SachsUpgradeNeutralNeutral
2026-06-05BernsteinUpgradeOutperformOutperform
2026-06-04UBSUpgradeNeutralNeutral
2026-06-04TD CowenUpgradeBuyBuy
Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Insider Holder
DateNameRelationQuantityDescription
2025-01-20CORONA GARY LOUISChief Financial Officer44.26KStock Award(Grant)
2024-08-01FONG IVAN KGeneral Counsel57.96KConversion of Exercise of derivative security
2026-04-26HOGAN RANDALL J IIIDirector49.00KStock Award(Grant)
2026-05-25MARINARO MICHAELOfficer70.59KConversion of Exercise of derivative security
2026-05-25MARTHA GEOFFREY SChief Executive Officer343.10KConversion of Exercise of derivative security
2024-08-01PARKHILL KAREN LChief Financial Officer99.12KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Blackrock Inc.113.18M9.32B8.84%
2026-03-30Vanguard Capital Management LLC83.33M6.87B6.51%
2026-03-30State Street Corporation61.74M5.09B4.82%
2026-03-30JPMORGAN CHASE & CO50.97M4.20B3.98%
2026-03-30Capital Research Global Investors41.93M3.45B3.28%
2026-03-30Vanguard Portfolio Management LLC33.45M2.76B2.61%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund40.76M3.36B3.18%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund32.58M2.68B2.55%
2026-05-30iShares Trust-iShares Core S&P 500 ETF16.89M1.39B1.32%
2026-05-30Fidelity Concord Street Trust-Fidelity 500 Index Fund16.41M1.35B1.28%
2026-05-30SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust15.45M1.27B1.21%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Value Index Fund11.87M978.25M0.93%
Dividend
DividendDate
0.722026-06-26
0.712026-03-27
0.712025-12-26
0.712025-09-26
0.712025-06-27
0.72025-03-28
Split
SplitDate
2 : 11999-09-27
2 : 11997-09-15
2 : 11995-09-29
2 : 11994-09-30
2 : 11991-08-30
2 : 11989-08-31